Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 48 No. 4, 2018 - Full Issue Stacked PDF
1
x
$
90.00
The Sex Effects Scale: Pilot Validation in a Healthy Population
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
One Hundred Courses of Cluster Maintenance Transcranial Magnetic Stimulation (CM TMS)—A Clinical Audit Study
1
x
$
30.00
Gender-Specific Differences in Depression and Treatment Response
1
x
$
30.00
View Cart
Checkout
Home
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 3 Articles
Tags:
antidepressant
,
deprenyl
,
depression
,
donald-s-robinson
,
medworks-media
,
monoamine-oxidase-inhibitors
,
phenelzine
,
psychopharmacology-bulletin
,
selegiline
,
transdermal
,
tranylcypromine
,
tyramine-sensitivity
Description
Description
Donald S. Robinson, MD
GENERAL PSYCHOPHARMACOLOGY
Monoamine Oxidase Inhibitors: A New Generation
Donald S. Robinson, MD
Related products
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Page load link
Go to Top
